The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials

被引:28
作者
Elster, EA
Hale, DA
Mannon, RB
Cendales, LC
Swanson, SJ
Kirk, AD
机构
[1] NIDDKD, Dept Hlth & Human Serv, Transplantat Branch, NIH, Bethesda, MD 20892 USA
[2] USN, Naval Med Res Ctr, Radiat & Combat Repair Dept, Washington, DC USA
[3] USA, Walter Reed Army Med Ctr, Organ Transplant Serv, Washington, DC USA
关键词
tolerance; costimulation blockade; lymphocyte depletion; mixed chimerism;
D O I
10.1016/j.trim.2004.05.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Organ transplantation has become a standard life-saving therapy for many causes of end stage organ failure. Although valuable, it remains hampered by the requirement for, and complications of, immunosuppression to prevent immune rejection of the transplanted organ. It is now clear that rejection can be avoided in some experimental systems without a requirement of immunosuppressive medication, and these experimental concepts are now making their way into the clinic in the form of early transplantation tolerance trials. This manuscript will discuss the most promising techniques for tolerance induction, namely, costimulation blockade, lymphocyte depletion, and mixed chimerism. Seminal preclinical studies will be cited and the results of initial clinical trials will be reviewed. The data to date indicate that while tolerance remains elusive, immunosuppression minimization is a feasible near-term alternative. Published by Elsevier B.V.
引用
收藏
页码:87 / 99
页数:13
相关论文
共 84 条
[1]   Heterologous immunity: an overlooked barrier to tolerance [J].
Adams, AB ;
Pearson, TC ;
Larsen, CP .
IMMUNOLOGICAL REVIEWS, 2003, 196 (01) :147-160
[2]   Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates [J].
Adams, AB ;
Shirasugi, N ;
Durham, MM ;
Strobert, E ;
Anderson, D ;
Rees, P ;
Cowan, S ;
Xu, HY ;
Blinder, Y ;
Cheung, M ;
Hollenbaugh, D ;
Kenyon, NS ;
Pearson, TC ;
Larsen, CP .
DIABETES, 2002, 51 (02) :265-270
[3]   Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9 [J].
Armstrong, N ;
Buckley, P ;
Oberley, T ;
Fechner, J ;
Dong, YC ;
Hong, XN ;
Kirk, A ;
Neville, D ;
Knechtle, S .
TRANSPLANTATION, 1998, 66 (01) :5-13
[4]  
Batty DS, 2001, AM J TRANSPLANT, V1, P179, DOI 10.1034/j.1600-6143.2001.10213.x
[5]  
Bluestone JA, 2000, J AM SOC NEPHROL, V11, P2141, DOI 10.1681/ASN.V11112141
[6]   Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse [J].
Brunkow, ME ;
Jeffery, EW ;
Hjerrild, KA ;
Paeper, B ;
Clark, LB ;
Yasayko, SA ;
Wilkinson, JE ;
Galas, D ;
Ziegler, SF ;
Ramsdell, F .
NATURE GENETICS, 2001, 27 (01) :68-73
[7]   Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease [J].
Bühler, LH ;
Spitzer, TR ;
Sykes, M ;
Sachs, DH ;
Delmonico, FL ;
Tolkoff-Rubin, N ;
Saidman, SL ;
Sackstein, R ;
McAfee, S ;
Dey, B ;
Colby, C ;
Cosimi, AB .
TRANSPLANTATION, 2002, 74 (10) :1405-1409
[8]   Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients [J].
Calne, R ;
Moffatt, SD ;
Friend, PJ ;
Jamieson, NV ;
Bradley, JA ;
Hale, G ;
Firth, J ;
Bradley, J ;
Smith, KGC ;
Waldmann, M .
TRANSPLANTATION, 1999, 68 (10) :1613-1616
[9]   Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients [J].
Calne, R ;
Friend, P ;
Moffatt, S ;
Bradley, A ;
Hale, G ;
Firth, J ;
Bradley, J ;
Smith, K ;
Waldmann, H .
LANCET, 1998, 351 (9117) :1701-1702
[10]  
CHASE MW, 1946, P SOC EXP BIOL MED, V61, P257